Materno-fetal Consequences of Symptomatic Dengue in Pregnant Wowen in French Guiana
NCT04989673 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 628
Last updated 2021-08-04
Summary
Symptomatic dengue virus infection in pregnant women could affect the mother, fetus and the newborn at birth. The risks of postpartum hemorrhage, prematurity and low birth weight are increased in dengue fever. Cases of vertical transmission have been described. This study therefore proposes to quantify these risks in a pregnant woman presenting a clinical picture of dengue fever through a prospective, longitudinal and comparative study.
Conditions
- Dengue
- Pregnancy Preterm
- Women
- Fever
- Parturition; Precipitate
- Infant, Newborn
Interventions
- OTHER
-
Biological sampling and collection (serum)
Detection of the dengue virus during the next scheduled biological assessment as part of normal pregnancy monitoring (additional tube of blood) among women from GNES and GNEF groups
- OTHER
-
Biological sampling and collection (placenta)
Detection of dengue virus in the placenta of GE patients (additional tube of placenta)
- OTHER
-
Questionnaire
Questionnaire on the patient's socio-economic conditions (10-minute interview with the Clinical Research Associate, CRA).
- OTHER
-
Data collection
Case Report Form will be completed by a Clinical Research Associate (CRA) from the medical file of the patient concerned and of her child at the 3 visits carried out (Pre inclusion V0 or Inclusion V1, Childbirth V2 and Maternity leave V3).
Sponsors & Collaborators
-
Centre Hospitalier de Kourou
collaborator UNKNOWN -
Centre Hospitalier de l'Ouest Guyanais
collaborator UNKNOWN -
Centres de Protection Maternelle Infantile Cayenne, Kourou et Saint-Laurent du Maroni
collaborator UNKNOWN -
Private physicians Cayenne, Kourou et Saint-Laurent du Maroni
collaborator UNKNOWN -
Private midwife Cayenne, Kourou et Saint-Laurent du Maroni
collaborator UNKNOWN -
Centre Hospitalier de Cayenne
lead OTHER
Principal Investigators
-
Gabriel CARLES · Centre Hospitalier de Saint-Laurent du Maroni
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-07-11
- Primary Completion
- 2015-02-12
- Completion
- 2015-07-11
Countries
- French Guiana
Study Locations
More Related Trials
-
Zika Virus Infection's Pregnancy Consequences in French Department of America
NCT02916732 ·Status: COMPLETED
-
Newborns of Obese Mothers
NCT02681588 ·Status: COMPLETED ·Phase: NA
-
Exploration of Pregnant Women's Reluctance Toward COVID-19 Vaccination
NCT06968117 ·Status: COMPLETED
-
Maternal and Neonatal Outcome in Severe Preeclampsia
NCT04126122 ·Status: UNKNOWN
-
Maternal and Fetal Outcomes in Pregnant Women With COVID -19,a Cross Sectional Study
NCT05608616 ·Status: COMPLETED
-
Clinical Study of Pregnant Women With COVID-19
NCT04701944 ·Status: UNKNOWN
-
Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy
NCT04075708 ·Status: COMPLETED
-
Northeast COVID-19 and Pregnancy Study Group
NCT04462367 ·Status: ACTIVE_NOT_RECRUITING
-
Vascular Biomarkers Predictive of the Progression From Hypertensive Disorders in Pregnancy to Preeclampsia in Pregnant Women
NCT04520048 ·Status: RECRUITING ·Phase: NA
-
Prevalence of Heterozygote Mothers for Pompe's Disease Among Mothers Having Delivered in French Guiana
NCT02903654 ·Status: COMPLETED
-
Observational Maternal COVID-19 Vaccination Study
NCT04826640 ·Status: COMPLETED
-
Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum: Evaluation of Clinical Practices in Five Maternity Hospitals in Île-de-France
NCT06841029 ·Status: COMPLETED
-
Inter- and Multidisciplinary, Cross-sectoral Feto-neonatal Pathway
NCT04514276 ·Status: UNKNOWN ·Phase: NA
-
Lifestyle Intervention for Women With Recent Pre-eclampsia or Gestational Diabetes Mellitus ('Mom's Healthy Heart')
NCT03993145 ·Status: COMPLETED ·Phase: NA
-
Antenatal Detection of Fetal Growth Restriction and Stillbirths Rate.
NCT01995968 ·Status: UNKNOWN
-
Gene Expression In Pregnancies Complicated by Preeclampsia
NCT00919360 ·Status: TERMINATED
-
Maternal Serum Vascular Endothelial Growth Factor in Pregnant Women With Foetal Growth Restriction
NCT02245477 ·Status: UNKNOWN
-
Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.
NCT03455387 ·Status: COMPLETED
-
Evaluation of Cardiovascular Risk After Preeclampsia in General Practitioners and Patients
NCT06059937 ·Status: COMPLETED
-
COVID-19 Infection and Fetal-neonatal Outcomes
NCT04699578 ·Status: UNKNOWN
-
Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A Case-control Study
NCT02610972 ·Status: COMPLETED
-
EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction
NCT01490489 ·Status: COMPLETED ·Phase: NA
-
Laboratory Diagnosis and Prognosis of Severe Dengue
NCT01421732 ·Status: COMPLETED
-
Study of the Physiology of Pre-eclampsia and Vascular IUGR With Constitution of a Biological Collection
NCT03626233 ·Status: UNKNOWN
-
Covid-19 Infection in Pregnancy
NCT04869202 ·Status: COMPLETED